ANCHOR LEAD: ONE FEDERAL AGENCY HAS CALLED FOR THE FDA TO STEP UP EFFORTS RELATED TO SUPPLEMENTS, ELIZABETH TRACEY REPORTS
The Government Accountability Office, known as the GAO, has recommended that the FDA be given additional powers to monitor manufacturers of dietary supplements as well as require more information from them. Expansion of adverse event reporting was also recommended. Redonda Miller, an internal medicine specialist at Johns Hopkins, supports an expanded role for the FDA.
MILLER: Herbals, dietary supplements, currently these medications do not have the same FDA oversight as prescription medications. This is a big issue, they do have safety concerns. These supplements may be laced with ingredients that the consumer doesn’t know about, and even more importantly, one could argue, are drug to drug interactions. Hopefully we will see better FDA oversight, hopefully we will have the FDA empowered and expanded to better oversee these supplements. :30
Miller says for now, consumers must inform their physicians which vitamins and supplements they’re taking. At Johns Hopkins, I’m Elizabeth Tracey.